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Abstract 
Purpose. Intraoperative radiation therapy (IORT) is a form of breast irradiation that is delivered 
in a single session at the time of partial mastectomy. In up to 10% of patients, planned IORT is 
not completed; this leads to wasted resources and decreased patient satisfaction. Our objective 
was to evaluate factors associated with failure to complete planned IORT.  
Methods and Materials. An IRB-approved review of planned IORT cases from 2011 to 2015 









tumor <3.0 cm, ER positive and clinically node negative. Discontinuation of planned IORT was 
at the discretion of the breast surgical and radiation oncologists.  
Results. 21 (15%) of 145 planned IORT cases were not completed. Reasons for failure to 
complete IORT included inadequate applicator to skin distance (n=15, 71%), altered wire 
localization findings the day of surgery (n=4, 19%), equipment failure (n=1, 5%) and 
hemodynamic instability (n=1, 5%). Significant surgeon variability was associated with failure to 
complete planned IORT (p<0.001). 
Conclusions. Insufficient skin-to-applicator spacing is the most common reason for failure to 
complete IORT. In this series, higher volume surgeons completed a greater proportion of IORT 
cases, suggesting a learning curve to patient selection or intraoperative technique.  
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Introduction 
 
Breast conserving surgery (BCS) followed by adjuvant whole breast external beam 
radiotherapy (EBRT) is a well-established option for patients with early-stage breast cancer (1-3). 
Adjuvant radiation totaling 45 to 50 Gy is typically delivered to the whole breast and 
administered in daily fractions for 5 consecutive weks. This dose may be supplemented by an 
additional boost of 10 to 16 Gy delivered to the tumor bed to further improve local control. For 
some patients, the financial and physical burden of daily travel may be taxing or even prohibitive, 
leading these patients to decline adjuvant radiation after partial mastectomy or choose 
mastectomy in order to avoid the need for radiation. Accelerated partial breast irradiation (APBI), 
including intraoperative radiation therapy (IORT), is increasingly accepted as an alternative to 
whole breast EBRT in selected patients with favorable tumor features. In these settings, IORT is 
associated with adequate local control and minimal orbidity(4, 5).  
In patients with early stage breast cancer, IORT may increase the utilization of 









planned in advance and requires coordination between the surgeon and radiation oncologist. In up 
to 7-11% of patients, planned IORT is not completed due to patient, equipment, or system factors 
(5, 6). Failure to complete planned IORT may lead to wasted resources (scheduled OR time and 
physician availability) and decreased patient satisfaction or compliance with recommended 
radiation. Improved patient and tumor selection or surgeon experience may help eliminate the 
failure to complete IORT. What is unknown is which factors—patient, clinical, system or 
provider-level—are associated with a failure to complete planned IORT, and if those factors can 
be identified or mitigated preoperatively. We sought to explore associations among these factors 
and failure to complete planned IORT at our institution through a retrospective review of all 
planned breast IORT cases. 
 
Methods and Materials 
 
We conducted an IRB-approved retrospective review of 145 consecutive patients with early 
stage breast cancer who elected breast conservation therapy with BCS and IORT from January 
2011 to January 2015 at Moffitt Cancer Center (Tamp, FL). Eligible patients included those 
aged 60 or older with the following clinical and pathologic criteria: (1) a pathologic diagnosis of 
invasive ductal or mammary carcinoma (mixed ductal and lobular components) less than or equal 
to 3.0 cm, (2) a clinically node negative axilla, (3) estrogen receptor (ER) positive and (4) the 
technical feasibility to accommodate a radiation applicator with a skin to applicator surface 
distance of at least 7 mm. Patients who had received neoadjuvant chemotherapy were excluded. 
Eligibility for IORT was ultimately at the discretion of the breast surgeon and radiation 
oncologist after discussion at a breast multidisciplinary tumor conference. 
The Intrabeam™ system (Figure 1) delivers low-energy photons (maximum 50 kV) at the tip 
of a 3.2 mm diameter tube. Spherical applicators of various sizes (2-6 cm) cover the tube and are 
placed in the tumor bed. The surface of the applicator receives 20 Gy and the absorbed dose 









system has been previously described(4). All patients u dergo wire localization by either 
preoperative ultrasound or stereotactic guidance and receive a preoperative radiotracer injection 
for sentinel lymph node biopsy (SLNB). At the SLNB is completed and specimens are sent for 
intraoperative histologic review. The wire localized partial mastectomy is then completed, and a 
specimen radiograph is obtained. Gross pathologic evaluation of margins is also performed at the 
time of the operation. Any margin grossly less than 5 mm is re-excised prior to placement of the 
IORT applicator. Following confirmation of grossly negative margins and a negative SLNB on 
touch prep, the IntrabeamTM delivery system is placed into the partial mastectomy cavity. 
Intraoperative ultrasound is performed to ensure tissue conformance with the applicator and a 
skin-to-device distance of at least 7 mm. Skin to applicator distance is measured sonographically 
in the superior, inferior, lateral and medical locations. Skin edges are retracted at least 1 cm from 
the applicator surface-shaft using the Lone Star Ret actor System (Cooper-Surgical Inc, Stafford, 
TX). IORT is then delivered to achieve 20 Gy of targeted radiation to the partial mastectomy 
cavity. The treatment ranges from 15 to 25 minutes, d pending on radiation applicator size. After 
completion of IORT, the partial mastectomy cavity is marked with surgical clips and the incision 
is closed in layers.  
Failure to completed planned IORT was at the discretion of the attending breast surgeon with 
the radiation oncologist and was made the day of surgery. Planned IORT was defined as a plan to 
deliver IORT on the day of surgery, and failure to completed IORT did not include cases that 
were rescheduled due to discussion at multidisciplinary tumor conferences or changes due to 
patient choice. 
For patients completing IORT, if final pathology confirmed histologically that margins and 
SLNB were negative, no further radiation therapy was administered. For cases of positive 
margins on final pathology (defined as tumor on ink), surgical re-excision was performed.  In 









margins) patients were treated with whole breast irrad ation. These cases were not considered as 
failures to complete IORT, as the IORT dose served as the boost dose of radiation.  
Descriptive statistics were performed. Normally distributed continuous variables were 
reported as mean and standard deviation and compared using a student t-test. Non-normally 
distributed variables were summarized by median and interquartile range (IQR) and compared 
using the Wilcoxon rank sum test. Categorical variables are reported as proportions and compared 
with a chi-square test. A p-value of 0.05 (two-sided t st) was declared as significant. All analyses 




A total of 145 consecutive planned IORT cases were r viewed. Of these cases, 21 (15%) 
were not completed as planned due to a decision made the day of surgery. The demographic, 
clinical and pathologic characteristics of cases resulting in failure to complete planned IORT 
compared to those where IORT was completed are summarized in Table 1. Age (p=0.35) and 
tumor size (p=0.40) did not differ between groups. Failure to complete planned IORT was 
associated with an increased need to take additional intr operative margins based on gross 
examination by pathology; additional margin excision occurred in 48% of cases where IORT was 
completed and 81% of cases for which planned IORT was not completed (p=0.005). The 
intraoperative decision to take additional margins wa  based on the findings of any margin less 
than 5 mm on the gross evaluation. Tumors that requir d additional intraoperative margins were 
slightly larger (median 10 mm versus 8 mm for no additional margins, p=0.02). After adjusting 
for tumor size, the need for additional intraoperative margins was not associated with failed IORT 
(OR 0.63, 95% CI 0.18-2.13, p=0.46). A majority of patients who did not complete planned 
IORT (81%) went on to receive postoperative whole breast EBRT whereas only 10% of those 









Women receiving EBRT after IORT were treated for 1) persistently positive margins requiring 
re-excision, 2) pathologic node positive disease, and 3) a change in histologic diagnosis. 
Reasons for failure to complete planned IORT are summarized in Table 2 and included 
inadequate skin-to-applicator distance after partial m stectomy (n=15, 71%), altered wire 
localization findings on the day of the procedure (n=4, 19%), equipment failure (n=1, 5%), and 
hemodynamic instability (n=1, 5%). When stratifying by surgeon, there were considerable 
differences in rates of failed IORT with rates ranging from 3-50% (p<0.001, Table 3). Surgeons 




Despite the overall excellent results obtained with breast conserving surgery (BCS) 
followed by whole breast EBRT, there is growing interest in APBI as a means to reduce the 
treatment and travel burden associated with five weks of daily radiation treatments. This is 
especially true for elderly patients, who are more lik ly to have favorable tumor biology and for 
whom the travel burden may be particularly arduous. In patients with early stage tumors and 
favorable characteristics, IORT offers the opportunity to complete radiation therapy in a single 
setting at the same time as partial mastectomy, potentially increasing the overall utilization of 
adjuvant radiation among this cohort. Executing IORT requires preoperative coordination with 
the surgeon, radiation oncologist and radiation physicist. Failure to complete planned IORT can 
lead to wasted time and resources, and be costly for both the patient and the health system.  
In our series, planned IORT was not completed in 17% of cases, which is comparable to 
the 11% reported in the TARGIT-A trial(5). The most common reason for failure to completed 
planned IORT was a skin to applicator distance of less than 0.7 cm. In 81% of these cases, 
compared to only 48% of completed cases (p=0.005), the surgeon took additional intraoperative 









additional surgical margins potentially decreases th  skin-to-applicator distance. One explanation 
for the need for additional intraoperative margins is a larger tumor size, which was noted in this 
series. While the difference in median tumor size was not significantly different between groups, 
tumor size was larger in cases requiring additional m rgins (p=0.02). Accurate localization or use 
of the localization wire in surgery may also play a role, as 50% of cases requiring additional 
intraoperative margins were for tumors less than 0.7cm in size. Several techniques can be used to 
potentially increase the skin-to-applicator distance including purse-string suture placement, tissue 
rearrangement and bolus saline injection. These techniques may help achieve an adequate skin-to-
applicator distance, but could also contribute to loca  ischemia which could increase skin toxicity 
rates. 
Provider variability was also associated with failure to complete planned IORT. Several 
possible factors may account for this finding. Most likely is that volume of experience with IORT 
may improve either patient selection or lumpectomy technique needed to achieve an adequate 
skin-to-applicator distance. In particular, the two-dimensional nature of mammography and the 
operator-dependent differences in ultrasound play a significant role in patient selection, but are 
only estimates of the actual skin-to-applicator distances observed intraoperatively. Variability 
among radiation oncologists may also contribute to these findings, as the initial recommended 
skin spacing mandated 10mm from skin to applicator, and gradually decreased to 7mm over time. 
However, the 7mm distance was not uniformly adopted by all faculty and likely contributed to 
discontinuation of planned therapy intraoperatively in some cases.  
Another consideration is that a small percentage of patients may have unexpected 
findings on imaging at the time of wire localization, such as lesions that appear multi-focal or 
larger than appreciated on initial imaging. In our se ies this occurred in 19% (n=3) of the failed 
cases (2% of total IORT cases). In these scenarios, the initial imaging had been performed outside 
our institution. Careful preoperative imaging may help to eliminate this as a cause of failure to 









anterior (superficial) margin, but the low incidenc would not provide justification for routine 
preoperative MRI if not otherwise indicated. 
 The strengths of the study include well-established s lection criteria and a consistent, 
uniform multidisciplinary treatment plan developed by fellowship trained breast specialists at a 
high volume cancer center. Despite these strengths, there are several important limitations. First, 
while this is a relatively large series of patients undergoing IORT at a single institution, this 
retrospective dataset remains underpowered for many outcomes and the overall median follow up 
is short (24 months). Second, while the single center design allows for uniformity in selection 
criteria and application of IORT, it limits the generalizability of the data to other centers.  
 
Conclusion 
Insufficient skin-to-applicator spacing is the most common reason for failure to complete 
IORT. In this series, higher volume surgeons completed a greater proportion of IORT cases, 
suggesting a learning curve to patient selection or i traoperative technique.  
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Figure 1. Intraoperative photo of breast intraoperative radiation therapy utilizing 
the Intrabeam system and the Lone Star Retractor system used for self-retaining 




Table 1.  Demographic and clinical features associated with aborted IORT. 






Age (years), mean ± SD 71.0 ± 7 69 ± 7 0.35 
Tumor Size (cm), mean 1.0 (0.3-3.5) 1.3 (0.2-3.5) 0.40 
Additional Intraoperative Margin n (%) 59 (48) 17 (81) 0.005 
Final Margin Positive n (%) 7 (6) 0 (0)  0.17 
Sentinel Lymph Node Positive n (%) 8 (6) 2 (9) 0.77 
Received Adjuvant WBRT n (%) 13 (10) 17 (81) <0.001 








Table 2.  Reasons for failure to complete planned IORT 
 N=21 
Inadequate Skin-to-applicator distance 15 (71) 
Altered wire localization findings 4 (19) 
Equipment failure 1 (5) 
Hemodynamic instability 1 (5) 







Table 3.  Completed versus Aborted IORT Cases by Surgeon. 



















n (% of failed to 
complete) 
Surgeon A 67 2 (3) 1 (50) 
Surgeon B 26 1 (4) 1 (100) 
Surgeon C 21 8 (27) 7 (88) 
Surgeon D 7 7 (50) 4 (58) 
Surgeon E 3 3 (50) 2 (67) 


















JSO Failed IORT Figure 1  . 
 
